全文获取类型
收费全文 | 4356篇 |
免费 | 586篇 |
国内免费 | 5篇 |
专业分类
4947篇 |
出版年
2022年 | 38篇 |
2021年 | 54篇 |
2020年 | 41篇 |
2019年 | 40篇 |
2018年 | 44篇 |
2017年 | 53篇 |
2016年 | 69篇 |
2015年 | 140篇 |
2014年 | 146篇 |
2013年 | 220篇 |
2012年 | 218篇 |
2011年 | 260篇 |
2010年 | 162篇 |
2009年 | 137篇 |
2008年 | 235篇 |
2007年 | 240篇 |
2006年 | 209篇 |
2005年 | 215篇 |
2004年 | 203篇 |
2003年 | 245篇 |
2002年 | 208篇 |
2001年 | 108篇 |
2000年 | 113篇 |
1999年 | 117篇 |
1998年 | 75篇 |
1997年 | 61篇 |
1996年 | 57篇 |
1995年 | 56篇 |
1994年 | 50篇 |
1993年 | 44篇 |
1992年 | 62篇 |
1991年 | 58篇 |
1990年 | 64篇 |
1989年 | 59篇 |
1988年 | 51篇 |
1987年 | 53篇 |
1986年 | 44篇 |
1985年 | 61篇 |
1984年 | 57篇 |
1983年 | 44篇 |
1982年 | 43篇 |
1981年 | 39篇 |
1980年 | 48篇 |
1979年 | 32篇 |
1978年 | 29篇 |
1977年 | 33篇 |
1976年 | 20篇 |
1975年 | 19篇 |
1974年 | 36篇 |
1971年 | 25篇 |
排序方式: 共有4947条查询结果,搜索用时 15 毫秒
931.
932.
Evans ME Jones DP Ziegler TR 《American journal of physiology. Gastrointestinal and liver physiology》2005,289(3):G388-G396
Glutamine (Gln) prevents apoptosis in intestinal epithelial cells, but the mechanism(s) remain unknown. Gln-derived metabolites include ammonia, glutamate (Glu), glutathione (GSH), and nucleotides. We previously showed that Gln potently inhibited apoptosis in cytokine-treated human colonic HT-29 cells; this effect was specific to Gln, unaffected by Glu, and unrelated to intracellular GSH. The current research examines mechanism(s) for Gln-induced antiapoptotic effects in HT-29 cells treated with TNF-alpha-related apoptosis-inducing ligand (TRAIL). Proliferating cells were treated with Gln or selected Gln metabolites for 24 h. Cells were then treated with TRAIL and Gln or its downstream metabolites, and apoptosis was assessed at 8 h after treatment. The purine and pyrimidine precursors inosine and orotate inhibited TRAIL-induced apoptosis. However, inhibition of purine synthesis with azaserine did not alter the potent antiapoptotic effect of Gln. In contrast, the pyrimidine synthesis inhibitor, acivicin, completely prevented this response. Supplementation with the pyrimidine uracil or the pyrimidine precursor orotate rescued the acivicin-induced blockade of Gln antiapoptotic action. Removal of bicarbonate, a substrate for pyrimidine synthesis, also inhibited the antiapoptotic effects of Gln. Uracil and thymine alone also significantly decreased TRAIL-induced apoptosis. The antiapoptotic effects of Gln were independent of DNA/RNA synthesis as measured by flow cytometry and bromodeoxyuridine incorporation. In conclusion, Gln prevents TRAIL-induced apoptosis in HT-29 cells through a mechanism involving the pyrimidine pathway. Our data also demonstrate the novel antiapoptotic effects of pyrimidine bases and their precursor orotate in these human intestinal cells. 相似文献
933.
Bone remodeling is a process of continuous resorption and formation/mineralization carried out by osteoclasts and osteoblasts, which, along with osteocytes, comprise the bone multicellular unit (BMU). A key component of the BMU is the bone remodeling compartment (BRC), isolated from the marrow by a canopy of osteoblast-like lining cells. Although much progress has been made regarding the cytokine-dependent and hormonal regulation of bone remodeling, less attention has been placed on the role of extracellular pH (pH(e)). Osteoclastic bone resorption occurs at acidic pH(e). Furthermore, osteoclasts can be regarded as epithelial-like cells, due to their polarized structure and ability to form a seal against bone, isolating the lacunar space. The major ecto-phosphatases of osteoclasts and osteoblasts, acid and alkaline phosphatases, both have ATPase activity with pH optima several units different from neutrality. Furthermore, osteoclasts and osteoblasts express plasma membrane purinergic P2 receptors that, upon activation by ATP, accelerate bone osteoclast resorption and impair osteoblast mineralization. We hypothesize that these ecto-phosphatases help regulate [ATP](e) and localized pH(e) at the sites of bone resorption and mineralization by pH-dependent ATP hydrolysis coupled with P2Y-dependent regulation of osteoclast and osteoblast function. Furthermore, osteoclast cellular HCO3(-), formed as a product of lacunar V-ATPase H(+) secretion, is secreted into the BRC, which could elevate BRC pH(e), in turn affecting osteoblast function. We will review the existing data addressing regulation of BRC pH(e), present a hypothesis regarding its regulation, and discuss the hypothesis in the context of the function of proteins that regulate pH(e). 相似文献
934.
TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone 下载免费PDF全文
Gizard F Robillard R Gross B Barbier O Révillion F Peyrat JP Torpier G Hum DW Staels B 《Molecular and cellular biology》2006,26(20):7632-7644
935.
936.
Mary Carrington Teri Kissner Bernard Gerrard Sergey Ivanov Stephen J. O'Brien Michael Dean 《American journal of human genetics》1997,61(6):1261-1267
The CCR5 gene encodes a cell-surface chemokine-receptor molecule that serves as a coreceptor for macrophage-tropic strains of HIV-1. Mutations in this gene may alter expression or function of the protein product, thereby altering chemokine binding/signaling or HIV-1 infection of cells that normally express CCR5 protein. Indeed, homozygotes for a 32-bp deletion allele of CCR5 (CCR5-delta 32), which causes a frameshift at amino acid 185, are relatively resistant to HIV-1 infection. Here we report the identification of 16 additional mutations in the coding region of the CCR5 gene, all but 3 of which are codon altering or "nonsynonymous." Most mutations were rare (found only once or twice in the sample); five were detected exclusively among African Americans, whereas eight were observed only in Caucasians. The mutations included 11 codon-altering nonsynonymous variants, one trinucleotide deletion, one chain-termination mutant, and three synonymous mutations. The high predominance of codon-altering alleles among CCR5 mutants (14/17 [81%], including CCR5-delta 32) is consistent with an adaptive accumulation of function-altering alleles for this gene, perhaps as a consequence of historic selective pressures. 相似文献
937.
Tong Y Claiborne A Pyzytulinska M Tao ZF Stewart KD Kovar P Chen Z Credo RB Guan R Merta PJ Zhang H Bouska J Everitt EA Murry BP Hickman D Stratton TJ Wu J Rosenberg SH Sham HL Sowin TJ Lin NH 《Bioorganic & medicinal chemistry letters》2007,17(13):3618-3623
A study on substitutions at the four open positions on the phenyl ring of the 1,4-dihydroindeno[1,2-c]pyrazoles as potent CHK-1 inhibitors is described. Bis-substitution at both the 6- and 7-positions led to inhibitors with IC(50) values below 0.3nM. The compound with the best overall activities (36) was able to potentiate the anti-proliferative effect of doxorubicin in HeLa cells by at least 47-fold. Physicochemical, metabolic, and pharmacokinetic properties of selected inhibitors are also disclosed. 相似文献
938.
Christopher M. de Fiebre Ping Wu Dean Notabartolo William J. Millard Edwin M. Meyer 《Neurochemical research》1994,19(6):643-648
The ability of Sendai virosomes or LipofectinTM to introduce an AAV vector into primary rat brain astroglial cultures was characterized. The pJDT95npy vector was constructed by inserting rat NPY cDNA downstream from the indigenous AAV p5, p19 and p40 promoters in pJDT95. LipofectinTM-mediated transfection with pJDT95npy (10 g) resulted in pronounced expression of several NPY mRNA species: p5-driven (3.3 kb), p19-driven (2.7 kb) and p40-driven (0.6, 0.8, 1.1, and 1.8 kb). Exposure to virosomally encapsulated pJDT95npy (50 or 100 ng) resulted in transient expression of some p40-driven mRNA species (0.8 and 1.8 kb). Neither method produced astroglia cells which synthesized mature NPY immunoreactivity. This demonstrates that an AAV-derived vector can drive gene expression in astroglia, that Sendai virosomes can infuse vectors into astroglia, but that the amount of DNA infused in this manner may limit long term expression. 相似文献
939.
940.
Whitby D Stossel A Gamache C Papin J Bosch M Smith A Kedes DH White G Kennedy R Dittmer DP 《Journal of virology》2003,77(14):8159-8165
Kaposi's sarcoma (KS) and lymphoproliferative diseases induced by KS-associated herpesvirus (KSHV/human herpesvirus 8) cause substantial morbidity and mortality in human immunodeficiency virus-infected individuals. To understand KSHV biology it is useful to investigate closely related rhadinoviruses naturally occurring in nonhuman primates. Here we report evidence for a novel KSHV homolog in captive baboon species (Papio anubis and other). Using degenerate PCR we identified a novel rhadinovirus, PapRV2, that has substantial sequence identity to two essential KSHV genes, the viral polymerase and thymidylate synthase. A subset of animals exhibited detectable PapRV2 viral load in peripheral blood mononuclear cells. Extensive serological analysis of nearly 200 animals in the colony demonstrated that the majority carried cross-reacting antibodies that recognize KSHV or macaque rhadinovirus antigens. Seroreactivity increased with age, similar to the age-specific prevalence of KSHV in the human population. This establishes baboons as a novel resource to investigate rhadinovirus biology, which can be developed into an animal model system for KSHV-associated human diseases, vaccine development, and therapy evaluation. 相似文献